missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ IFN beta Recombinant Rabbit Monoclonal Antibody (23GB6230)
Description
IFN beta Recombinant Monoclonal Antibody for ICC/IF, Western Blot
Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by Natural IFN-producing cells (IPCs) as part of the host immune response. IFNs can also inhibit the development of tumors. IFN-beta binding results in the activation of the tyrosine kinases Jak1 and Tyk2, phosphorylation of members of the STAT family of transcription factors, and the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.
Specifications
Specifications
| Antigen | IFN beta |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | 23GB6230 |
| Concentration | 0.8 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 |
| Gene | Ifnb1 |
| Gene Accession No. | P01574, P01575 |
| Gene Alias | Fibroblast interferon; Ifb; IFF; IFN b; IFN β; IFNB; Ifnb1; IFNbeta; IFN-beta; IFNβ; Interferon; Interferon b; Interferon beta; interferon beta 1; interferon beta 1, fibroblast; interferon beta protein; interferon, beta 1; interferon, beta 1, fibroblast; interferon-beta; RP11-113D19.1 |
| Show More |